NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Artificial Intelligence Skills in Demand in India's CDMO Sector

A recent report by CIEL HR has revealed a sharp shift in hiring trends in India's Contract Development and Manufacturing Organisation (CDMO) sector, with artificial intelligence (AI) skill demand jumping nearly three-fold in two years between 2023 and 2025.

According to the report, AI-linked skill demand in the CDMO sector surged to 17.2 per cent in 2025 from 6.2 per cent in 2023. The report further highlighted that AI demand remained highest in technology and digital roles at nearly 38 per cent. This trend is a reflection of the increasing importance of AI in the sector, with AI becoming central to how research is accelerated, manufacturing is optimised and client commitments are delivered.

The CIEL HR report is based on inputs from over 50 CDMO and pharma manufacturing organisations operating in India across calendar years 2023, 2024 and 2025. These companies collectively represent API manufacturing, formulations, biologics, speciality pharma, contract manufacturing and integrated development platforms. Demand intelligence was derived from more than 50 companies by analysing hiring trends across calendar years.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Segment20232025
Technology and Digital26.5%38.0%
Research and Development15.6%24.0%
Manufacturing and Operations10.2%17.2%
Other47.7%20.8%

The report found that overall, the CDMO sector saw a 52 per cent increase in talent demand between 2023 and 2025, indicating sustained capacity expansion and rising complexity in outsourced pharmaceutical programmes. Manufacturing and operations emerged as the largest segments, accounting for 1,820 roles in 2025. However, growth in these functions remained the slowest among all positions, at around 8 per cent year-on-year.

The report also highlighted a widening gap between demand and available talent, particularly in high-value roles. While demand for AI skills in research and development roles increased to 24 per cent, the supply of AI-skilled talent in these functions remained below 1 per cent, creating a significant execution constraint.

Geographic concentrations were also outlined, with over 60 per cent of CDMO talent clustered across fewer key states, led by Maharashtra, Gujarat and Telangana, increasing dependence on limited talent pools. Emerging hubs like Tamil Nadu, Andhra Pradesh and NCR have a lot of catch-up to do, the report stated.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The report's findings suggest that the CDMO sector is entering a phase where competitive advantage will be the ability to integrate intelligence into every layer of operations. As the sector continues to evolve, the challenge ahead will be building depth of talent that can translate this potential into consistent outcomes at scale.

Investor Takeaway

Investors should consider the growing demand for AI-linked skills in the CDMO sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.